JENNA NICHOLS: Open Payments
NPI 1558042820 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 51 payments from 17 companies in 2025. Trend: 2023 $82 · 2024 $1,347 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $190 |
| AstraZeneca Pharmaceuticals LP | 5 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Novo Nordisk Inc | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Exact Sciences Corporation | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $29 |
Products named: AIRSUPRA, Kerendia, VRAYLAR, UBRELVY, CAPLYTA, QULIPTA, REXULTI, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
